Futebol Clube do Porto - Futebol S.A.D. (FCP)
Euronext Lisbon · Portugal · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 2.560 |
|---|---|
| 52-week range | 2.500 – 4.180 |
| Return, 1 month / 3 months | −7.2% / −14.7% |
| Return, 1 year / 3 years | −5.2% / +128.6% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 73.1% |
| Worst drawdown (1 year) | -40.2% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Futebol Clube do Porto - Futebol S.A.D. is a Portuguese football club based in Porto. It runs professional football teams that compete in domestic league and cup competitions and in European club tournaments, and it also develops youth players through its academy. Its customers are supporters, members and spectators who attend matches and follow the club, along with commercial partners and broadcasters that carry its games. The club also operates a stadium and related sporting and commercial activities.
Futebol Clube do Porto - Futebol S.A.D. trades under the code FCP on the Euronext Lisbon in Portugal, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Futebol Clube do Porto - Futebol S.A.D. (FCP) trades on the Euronext Lisbon in Portugal. It last closed at EUR 2.560 on 27 October 2026.
Its price-based Market X-Ray is 18 out of 100 (a weak price profile), ranking 35 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.2% and over the last three months it fell 14.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 10 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.3% | ||
| From 52-week high | -38.8% | ||
| Momentum | 33 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.7% | ||
| 6-month return | -6.6% | ||
| 12-month return, skipping the last month | 2.2% | ||
| Stability (higher is calmer) | 7 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 73.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.2% | ||
| Liquidity | 22 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −8.6% |
|---|---|
| 1 month | −7.2% |
| 3 months | −14.7% |
| 6 months | −6.6% |
| 1 year | −5.2% |
| 3 years | +128.6% |
| 5 years | +158.6% |
Signals
| 50-day / 200-day average | 2.753 / 2.951 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.067 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.